Clinical trial of gene therapy with dual AAV vectors for retinitis pigmentosa in patients with Usher syndrome type IB

Projektinformationen

UshTher

ID Finanzhilfevereinbarung: 754848

DOI 10.3030/754848

Projekt abgeschlossen

EK-Unterschriftsdatum 27 November 2017

Startdatum 1 Januar 2018

Enddatum 30 Juni 2023

Finanziert unter

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Gesamtkosten € 5 998 515,75

EU-Beitrag € 5 998 515,75

Koordiniert durch

FONDAZIONE TELETHON ETS
Italien

CORDIS bietet Links zu öffentlichen Ergebnissen und Veröffentlichungen von HORIZONT-Projekten.

Links zu Ergebnissen und Veröffentlichungen von RP7-Projekten sowie Links zu einigen Typen spezifischer Ergebnisse wie Datensätzen und Software werden dynamisch von OpenAIRE abgerufen.

Leistungen

Dokumente, Berichte (19)

Official logo of UshTher
Flyer publication with clinical trial results
Communication of participation to meetings and conferences RP1

Communication of participation to meetings and conferences

Flyer publication
Contact database of relevant representatives of stakeholder groups
Report Planned communication activity
Final report on project dissemination and exploitation
Communication of participation to meetings and conferences final RP

Communication of participation to meetings and conferences

Periodic report on project dissemination and exploitation RP2
UshTher Clinical study - Report on status of posting results
Communication of peer reviewed high impact publications 2
Communication of participation to meetings and conferences RP2

Communication of participation to meetings and conferences

Periodic report on project dissemination and exploitation
Detailed dissemination plan
Communication of peer reviewed high impact publications 3
Establishment of the Data Safety Monitoring Board (DSMB)
Dissemination of the trial results through the project website
Connection with patient organization
Communication of peer reviewed high impact publications 1

Websites, Patentanmeldungen, Videos etc. (6)

Social Network strategy plan
Open Day event 1
Website and intranet portal
Open Day event 3
Report of completed communication activities
Open Day event 2

Veröffentlichungen

Fachlich begutachtete Artikel (3)

Has retinal gene therapy come of age? From bench to bedside and back to bench

Autoren: Ivana Trapani, Alberto Auricchio
Veröffentlicht in: Human Molecular Genetics, Ausgabe 28/R1, 2019, Seite(n) R108-R118, ISSN 0964-6906
Herausgeber: Oxford University Press
DOI: 10.1093/hmg/ddz130

Genotype–phenotype correlation in patients with Usher syndrome and pathogenic variants in MYO7A : implications for future clinical trials

Autoren: Lilián Galbis‐Martínez, Fiona Blanco‐Kelly, Gema García‐García, Almudena Ávila‐Fernández, Teresa Jaijo, Carla Fuster‐García, Irene Perea‐Romero, Olga Zurita‐Muñoz, Belén Jimenez‐Rolando, Ester Carreño, Blanca García‐Sandoval, José M. Millán, Carmen Ayuso
Veröffentlicht in: Acta Ophthalmologica, 2021, ISSN 1755-375X
Herausgeber: Wiley-Blackwell
DOI: 10.1111/aos.14795

Genetics, pathogenesis and therapeutic developments for Usher syndrome type 2.

Autoren: M. Stemerdink, B. García-Bohórquez, R. Schellens, G. Garcia-Garcia, E. Van Wijk & J. M. Millan
Veröffentlicht in: Human Genetics, 2021, ISSN 1434-5161
Herausgeber: Springer Verlag
DOI: 10.1007/s00439-021-02324-w